Neuralstem, Inc. is a biopharmaceutical company based in San Diego, CA, specializing in the research and development of innovative therapies for nervous system diseases. Utilizing their neural stem cell technology, the company is focused on finding novel treatments for conditions such as major depressive disorder, Angelman syndrome, cognitive impairment, neuropathy associated with diabetes, and stroke.
With a diverse pipeline of clinical programs, Neuralstem is actively developing both small molecule and stem cell therapy approaches. Their lead asset, NSI-189, is currently in clinical development for major depressive disorder and in preclinical development for various other indications. Committed to advancing their research, Neuralstem seeks partnerships and collaborations to support their programs and bring their innovative nervous system therapies to market.
Generated from the website